UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Osteoporosis international, 2014-10, Vol.25 (10), p.2359-2381

2014

Volltextzugriff (PDF)

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013–2014---supplementary presentation

Osteoporosis international, 2017-08, Vol.28 (8), p.2319-2320

Cosman, F.

2017

Volltextzugriff (PDF)

Fragility fractures of the hip and femur: incidence and patient characteristics

Osteoporosis international, 2010-03, Vol.21 (3), p.399-408

2010

Volltextzugriff (PDF)

Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis

Osteoporosis international, 2020-06, Vol.31 (6), p.1025-1048

2020

Volltextzugriff (PDF)

Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study

Osteoporosis international, 2022-08, Vol.33 (8), p.1703-1714

2022

Volltextzugriff (PDF)

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014

Osteoporosis international, 2017-06, Vol.28 (6), p.1857-1866

2017

Volltextzugriff (PDF)

Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials

Osteoporosis international, 2024-07, Vol.35 (7), p.1195-1204

2024

Volltextzugriff (PDF)

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

The New England journal of medicine, 2007-05, Vol.356 (18), p.1809-1822

2007

Volltextzugriff (PDF)

Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1033-1040

2019

Volltextzugriff (PDF)

Erratum to: Clinician’s guide to prevention and treatment of osteoporosis

Osteoporosis international, 2015-07, Vol.26 (7), p.2045-2047

2015

Volltextzugriff (PDF)

Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective?

Osteoporosis international, 2020-12, Vol.31 (12), p.2321-2335

2020

Volltextzugriff (PDF)

Recent insights in the use of teriparatide and antiresorptive combinations and sequences

Bone (New York, N.Y.), 2011-05, Vol.48, p.S55-S55

Cosman, F

2011

Volltextzugriff (PDF)

Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial

Osteoporosis international, 2022-01, Vol.33 (1), p.239-250

2022

Volltextzugriff (PDF)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Osteoporosis international, 2019-06, Vol.30 (6), p.1187-1194

2019

Volltextzugriff (PDF)

Unmasking romosozumab: response to commentsby Uzoigwe et al

Osteoporosis international, 2017-06, Vol.28 (6), p.2021-2022

2017

Volltextzugriff (PDF)

Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis

Osteoporosis international, 2021-09, Vol.32 (9), p.1879-1888

2021

Volltextzugriff (PDF)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Osteoporosis international, 2020-08, Vol.31 (8), p.1603-1605

2020

Volltextzugriff (PDF)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Osteoporosis international, 2020-05, Vol.31 (5), p.1017-1018

2020

Volltextzugriff (PDF)

Selective Estrogen Receptor Modulators: Clinical Spectrum

Endocrine reviews, 1999-06, Vol.20 (3), p.418-434

Cosman, F.

1999

Volltextzugriff (PDF)

Parathyroid Hormone Added to Established Hormone Therapy: Effects on Vertebral Fracture and Maintenance of Bone Mass After Parathyroid Hormone Withdrawal

Journal of bone and mineral research, 2001-05, Vol.16 (5), p.925-931

2001

Volltextzugriff (PDF)

Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study

Journal of bone and mineral research, 2001-10, Vol.16 (10), p.1846-1853

2001

Volltextzugriff (PDF)

A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates

Osteoporosis international, 2016-01, Vol.27 (1), p.377-386

2016

Volltextzugriff (PDF)

Constant mineralization density distribution in cancellous human bone

Bone (New York, N.Y.), 2003-03, Vol.32 (3), p.316-323

2003

Volltextzugriff (PDF)

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

Journal of neuroimmunology, 2003, Vol.134 (1), p.128-132

2003

Volltextzugriff (PDF)

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2016-10, Vol.375 (16), p.1532-1543

2016

Volltextzugriff (PDF)

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(196)
Humans
(184)
Life Sciences & Biomedicine
(183)
Female
(128)
Biological And Medical Sciences
(88)
Endocrinology & Metabolism
(85)
Middle Aged
(66)
Aged
(58)
Medical Sciences
(52)
Male
(50)
Bone Density
(44)
Osteoporosis
(41)
Fundamental And Applied Biological Sciences. Psychology
(37)
Adult
(32)
Osteoporosis, Postmenopausal - Drug Therapy
(31)
Orthopedics
(29)
Medicine
(28)
Endocrinology
(27)
Medicine & Public Health
(27)
Animals
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013–2014---supplementary presentation

Fragility fractures of the hip and femur: incidence and patient characteristics

Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis

Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014

Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

Erratum to: Clinician’s guide to prevention and treatment of osteoporosis

Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective?

Recent insights in the use of teriparatide and antiresorptive combinations and sequences

Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Unmasking romosozumab: response to commentsby Uzoigwe et al

Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Selective Estrogen Receptor Modulators: Clinical Spectrum

Parathyroid Hormone Added to Established Hormone Therapy: Effects on Vertebral Fracture and Maintenance of Bone Mass After Parathyroid Hormone Withdrawal

Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study

A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates

Constant mineralization density distribution in cancellous human bone

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Suchergebnisse filtern